TUDOR INVESTMENT CORP ET AL
Q4 2022 13F-HR Holdings
Net value change ($000)
+423,994
(9.2%)
New positions
443
Sold out positions
486
Turnover %
53.8%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q3 2022
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| Horizon Therapeutics Public Ltd Co | 73,819 | NEW |
| Coupa Software Inc | 44,825 | 643.4% |
| COWEN INC. | 27,741 | 127.7% |
| BMY | 19,231 | 2523.8% |
| Poshmark, Inc. | 18,716 | 11482.2% |
| MTB | 17,691 | NEW |
| MET | 17,215 | 6447.6% |
| CVS | 16,886 | 1825.5% |
| LLY | 16,572 | 252.4% |
| MBLY | 15,924 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| ALLEGHANY CORP /DE | -93,365 | -100.0% |
| Biohaven Pharmaceutical Holding Co Ltd. | -71,806 | -100.0% |
| SPY | -42,896 | -100.0% |
| Zendesk, Inc. | -42,301 | -100.0% |
| TWTR | -41,551 | -100.0% |
| EEM | -33,838 | -47.1% |
| MA | -19,744 | -97.8% |
| ELV | -18,791 | -100.0% |
| ChemoCentryx, Inc. | -18,443 | -100.0% |
| NKE | -18,412 | -98.2% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
987,730
(19.5% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|